Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for postoperative pain after cesarean section
IRCT20190905044705N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in postoperative pain (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Pain relief. Started Dec 2021; status: completed.
02
Drugs
oxytocin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190905044705N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190905044705N1.